Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation (Q59315414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Koen van Besien

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

D A Pollyea

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A S Artz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

W Stock

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

C Daugherty

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

L Godley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

O M Odenike

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

E Rich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

S M Smith

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

T Zimmerman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Y Zhang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

D Huo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

10 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1027-1032

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705852

7 January 2020

exact match

0 references

cites work

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

Outcomes of patients with acute leukaemia who relapsed after reduced-intensity stem cell transplantation from HLA-identical or one antigen-mismatched related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Comorbidity and beyond: pre-transplant clinical assessment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Chimerism does not predict for outcome after alemtuzumab based conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Loss of the Y chromosome in bone marrow cells: results on 1907 consecutive cases of leukaemia and preleukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Second allogeneic transplantation after failure of first autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Leukemia: management of relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705852

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705852

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846595%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference